Telmisartan Lowers Albuminuria in Type 2 Diabetic Patients Treated With Angiotensin Enzyme Inhibitors

Advances in Medical Sciences - Netherlands
doi 10.2478/v10039-009-0015-6
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Elsevier BV

Related search

Additive Antioxidative Effects of Azelnidipine on Angiotensin Receptor Blocker Olmesartan Treatment for Type 2 Diabetic Patients With Albuminuria

Hypertension Research
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2011English

Angiotensin Converting Enzyme Inhibitors and Diabetic Nephropathy.

BMJ
1992English

Combination Therapy With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Antagonists in the Treatment of Patients With Type 2 Diabetes Mellitus

Archives of Internal Medicine
2003English

Effects of Telmisartan on Insulin Resistance in Japanese Type 2 Diabetic Patients

Internal Medicine
Internal MedicineMedicine
2010English

Podocyte Number in Normotensive Type 1 Diabetic Patients With Albuminuria

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2002English

Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Angiotensin-Converting Enzyme 2 and Treatment With Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Type 1 Receptor Blockers

European Journal of Preventive Cardiology
EpidemiologyCardiovascular MedicineCardiology
2020English

Sodium Sensitivity Related to Albuminuria Appearing Before Hypertension in Type 2 Diabetic Patients

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2001English

Sodium-Glucose Cotransporter 2 Inhibitors Reduce Prandial Insulin Doses in Type 2 Diabetic Patients Treated With the Intensive Insulin Therapy

Journal of Clinical Medicine Research
2018English

Polymorphism of Angiotensin-Converting Enzyme (Rs4340) and Diabetic Nephropathy in Caucasians With Type 2 Diabetes Mellitus

Balkan Journal of Medical Genetics
Genetics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy